Rebecca King

At Keller Postman, Rebecca currently helps manage the firm’s litigation against the manufacturers of hair relaxer products that have been associated with uterine, endometrial, and ovarian cancer. In the Acetaminophen-ASD-ADHD Products Liability Litigation, she is a member of the Science Subcommittee and the Early Vetting and Bellwether Selection Subcommittee.

Before joining Keller Postman, Rebecca was a partner at Tracey, Fox, King & Walters in Houston, where she successfully negotiated several multi-million-dollar settlements on behalf of her clients in pharmaceutical and medical device cases. Rebecca had the honor of representing women and their families against manufacturers of surgical devices associated with spreading undiagnosed uterine and endometrial cancer. She also represented clients with type 2 diabetes, who were seriously injured by SGLT-2 inhibitor drugs.

Prior to joining Tracey, Fox, King & Walters, Rebecca was an associate at Blizzard, McCarthy & Nabers. At Blizzard, McCarthy & Nabers, she represented families of children born with severe birth defects due to medications taken during pregnancy. She also represented individuals harmed by unsafe medical devices and ephedrine-containing dietary supplements.

Rebecca served as co-lead counsel for the coordinated Storz power morcellator litigation consolidated in California. She was also lead counsel in the Jardiance Fournier’s gangrene litigation consolidated in Connecticut. In 2016, she was appointed to the Plaintiffs’ Steering Committee in the Ethicon power morcellator federal MDL litigation.

Rebecca graduated from Baylor University School of Law. She earned her undergraduate degree from Ouachita Baptist University, where she majored in history and political science. While an undergraduate, she also attended Salzburg College in Salzburg, Austria.

Rebecca is licensed to practice law in Texas, Pennsylvania and Arkansas only.